This company listing is no longer active
Nanexa Future Growth
Future criteria checks 1/6
Nanexa is forecast to grow earnings and revenue by 77.4% and 16% per annum respectively. EPS is expected to grow by 95.2% per annum. Return on equity is forecast to be 14.8% in 3 years.
Key information
77.4%
Earnings growth rate
95.2%
EPS growth rate
| Medical Equipment earnings growth | 25.2% |
| Revenue growth rate | 16.0% |
| Future return on equity | 14.8% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 70 | -7 | -12 | -5 | 2 |
| 12/31/2024 | 93 | 11 | 5 | 12 | 2 |
| 12/31/2023 | 55 | -39 | -78 | -46 | 2 |
| 9/30/2023 | 52 | -43 | -39 | -8 | N/A |
| 6/30/2023 | 47 | -49 | -41 | -8 | N/A |
| 3/31/2023 | 35 | -55 | -46 | -12 | N/A |
| 12/31/2022 | 27 | -59 | -43 | -8 | N/A |
| 9/30/2022 | 24 | -54 | -77 | -43 | N/A |
| 6/30/2022 | 19 | -50 | -74 | -40 | N/A |
| 3/31/2022 | 18 | -42 | -59 | -30 | N/A |
| 12/31/2021 | 18 | -36 | -51 | -25 | N/A |
| 9/30/2021 | 19 | -31 | -64 | -24 | N/A |
| 6/30/2021 | 22 | -27 | -49 | -18 | N/A |
| 3/31/2021 | 22 | -25 | -44 | -18 | N/A |
| 12/31/2020 | 21 | -22 | -38 | -17 | N/A |
| 9/30/2020 | 18 | -19 | -23 | -13 | N/A |
| 6/30/2020 | 13 | -18 | -25 | -14 | N/A |
| 3/31/2020 | 11 | -13 | -18 | -7 | N/A |
| 12/31/2019 | 9 | -13 | -20 | -9 | N/A |
| 9/30/2019 | 7 | -12 | -16 | -9 | N/A |
| 6/30/2019 | 6 | -11 | -15 | -9 | N/A |
| 3/31/2019 | 4 | -12 | -17 | -11 | N/A |
| 12/31/2018 | 4 | -11 | -13 | -7 | N/A |
| 9/30/2018 | 4 | -9 | -13 | -7 | N/A |
| 6/30/2018 | 4 | -9 | -12 | -6 | N/A |
| 3/31/2018 | 4 | -8 | -14 | -7 | N/A |
| 12/31/2017 | 3 | -8 | -12 | -5 | N/A |
| 9/30/2017 | 3 | -8 | -8 | -6 | N/A |
| 6/30/2017 | 2 | -8 | N/A | -6 | N/A |
| 3/31/2017 | 2 | -7 | N/A | -5 | N/A |
| 12/31/2016 | 2 | -6 | N/A | -6 | N/A |
| 9/30/2016 | 2 | -6 | N/A | -4 | N/A |
| 6/30/2016 | 2 | -6 | N/A | -5 | N/A |
| 3/31/2016 | 2 | -5 | N/A | -4 | N/A |
| 12/31/2015 | 2 | -4 | N/A | -3 | N/A |
| 9/30/2015 | 1 | -2 | N/A | -3 | N/A |
| 6/30/2015 | 0 | -2 | N/A | 0 | N/A |
| 3/31/2015 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2014 | N/A | -1 | N/A | 1 | N/A |
| 4/30/2014 | 1 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NANEXA BTA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NANEXA BTA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NANEXA BTA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NANEXA BTA's revenue (16% per year) is forecast to grow faster than the Swedish market (1% per year).
High Growth Revenue: NANEXA BTA's revenue (16% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NANEXA BTA's Return on Equity is forecast to be low in 3 years time (14.8%).